Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Radix rehmanniae praeparata is the processed (steamed) root of Rehmannia glutinosa, a perennial herb widely used in Traditional Chinese Medicine (TCM). Known as Shu Di Huang in Chinese medicine, it is considered a key blood tonic and is traditionally used to nourish kidney-yin and replenish essence and marrow. It is commonly prescribed for conditions such as anemia, menstrual disorders, symptoms of yin deficiency (like hot flushes or night sweats), and to promote healthy blood circulation. Pharmacologically, radix rehmanniae praeparata contains active compounds such as catalpol that exhibit antioxidant, anti-inflammatory, neuroprotective properties and may modulate immune function. Some studies suggest it can reduce neuronal apoptosis and improve energy metabolism in animal models. However, robust clinical evidence for its efficacy remains limited[1][2][3][4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on radix rehmanniae praeparata.